Year ended 31 December
|
€’000 |
Note |
2010 |
2009 |
|
Sales |
1,513,596 |
1,316,595 |
|
|
Cost of sales |
(511,117) |
(441,813) |
|
|
Gross profit |
1,002,479 |
874,782 |
|
|
Other income |
58,090 |
52,744 |
|
|
Selling and marketing expenses |
(643,544) |
(559,456) |
|
|
Administrative expenses |
(259,674) |
(222,629) |
|
|
Operating profit |
157,351 |
145,441 |
|
|
Analysis of operating profit: |
|||
|
Adjusted operating profit |
168,123 |
146,782 |
|
|
Restructuring |
(721) |
(1,341) |
|
|
Impairment Iran |
(10,051) |
– |
|
|
Operating profit |
157,351 |
145,441 |
|
|
Financial income |
17,924 |
3,059 |
|
|
Financial expenses |
(40,058) |
(31,247) |
|
|
Net financing costs |
(22,134) |
(28,188) |
|
|
Net profit before income tax |
135,217 |
117,253 |
|
|
Current tax |
(33,201) |
(20,126) |
|
|
Deferred tax |
15,521 |
3,185 |
|
|
Total income tax expense |
(17,680) |
(16,941) |
|
|
Net profit |
117,537 |
100,312 |
|
|
Earnings per share, € |
|||
|
Basic |
2.07 |
1.77 |
|
|
Diluted |
2.06 |
1.76 |
The attached notes form an integral part of the consolidated financial statements.